Skip to Main Content

Author Details

Ruth M Ruprecht
University of Texas San Antonio
1971
202
47
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37613382Elucidating Vaccine Trafficking Mechanisms using Multimodal Imaging.Microsc Microanal2023
35273592Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.Front Immunol2022
35645210Antibody Light Chains: Key to Increased Monoclonal Antibody Yields in Expi293 Cells?Antibodies (Basel)2022
35857825Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity.Sci Transl Med2022
33385332Phage Display-Directed Discovery of LEDGF/p75 Binding Cyclic Peptide Inhibitors of HIV Replication.Mol Ther2021
33658998Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.Front Immunol2021
34860581A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity.Sci Immunol2021
34793582Localization of infection in neonatal rhesus macaques after oral viral challenge.PLoS Pathog2021
34402452Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.AIDS2021
34413855Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges.Front Immunol2021
34061907PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposure.PLoS Pathog2021
34091299Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates.Biomaterials2021
32343743Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.PLoS Pathog2020
32849652Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered.Front Immunol2020
32130229Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.PLoS One2020
30760566Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.J Virol2019
31771162Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion.Vaccines (Basel)2019
31035848Lymphocytes upregulate CD36 in adipose tissue and liver.Adipocyte2019
29093095Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.J Virol2018
29743361Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.J Virol2018
29762161Anti-HIV IgM protects against mucosal SHIV transmission.AIDS2018
29563297Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.J Virol2018
29097089Anti-HIV Passive Immunization: New Weapons in the Arsenal.Trends Microbiol2017
28463876Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.AIDS2017
28422786Antibody-mediated immune exclusion of HIV.Curr Opin HIV AIDS2017
29176985Mucosal IgA Responses: Damaged in Established HIV Infection-Yet, Effective Weapon against HIV Transmission.Front Immunol2017
25174584Massive occlusive thrombosis of the pulmonary artery in pigtailed macaques chronically infected with R5-tropic simian-human immunodeficiency virus.J Med Primatol2015
25769884Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.Vaccine2015
24444350Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.Retrovirology2014
25499540Are anti-HIV IgAs good guys or bad guys?Retrovirology2014
25245933Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.Vaccine2014
23528732Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.Virology2013
24278022The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells.PLoS Pathog2013
24098702Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.PLoS One2013
23840566Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression.PLoS One2013
23775002Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission.AIDS2013
23800339Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.Retrovirology2013
23758766Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.Retrovirology2013
23388727Novel biopanning strategy to identify epitopes associated with vaccine protection.J Virol2013
21941166High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.AIDS2012
22970187Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.PLoS One2012
22737224Isolation of monoclonal antibodies with predetermined conformational epitope specificity.PLoS One2012
22828501Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication.Mol Ther2012
22427893Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.PLoS One2012
21244649Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV.J Immune Based Ther Vaccines2011
22081778No acquisition: a new ambition for HIV vaccine development?Curr Opin Virol2011
21829749Schistosoma mansoni enhances host susceptibility to mucosal but not intravenous challenge by R5 Clade C SHIV.PLoS Negl Trop Dis2011
21799765Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.PLoS One2011
21895680Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.J Med Primatol2011
21957314Efficiency of neutralizing antibodies targeting the CD4-binding site: influence of conformational masking by the V2 loop in R5-tropic clade C simian-human immunodeficiency virus.J Virol2011
  • 1 - 50 of 202

Recommended Authors

Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 2
Kei Sato
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 0
Kara Jensen
University of North Carolina
Career Start Year 2006
Number of shared co-authors 2
Kristina De Paris
University of North Carolina at Chapel Hill Chapel Hill
Career Start Year 2004
Number of shared co-authors 2
Jason M Brenchley
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 1
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 2
Cynthia A Derdeyn
University of Washington
Career Start Year 1995
Number of shared co-authors 3
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 3
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 4
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 0
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 2
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 4
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 5
Michael C Keefer
MK University of Rochester
Career Start Year 1986
Number of shared co-authors 2
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 1
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 0
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 2
Timothy R Fouts
Profectus BioSciences Inc.
Career Start Year 1981
Number of shared co-authors 0
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 4
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 4
Donald S Burke
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 0
James E Crowe
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 3
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 1
Eric Hunter
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 2
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 5

Collaborators

David C Montefiori
Co-authored papers 31
Samir K Lakhashe
Texas Biomedical Research Institute
Co-authored papers 26
Francois Villinger
Co-authored papers 20
Lori R Hill
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Siqi Gong
New Iberia Research Center, University of Louisiana at Lafayette
Co-authored papers 6
Janet Andersen
Harvard School of Public Health
Co-authored papers 5
Sarah J Ratcliffe (CM4AI)
University of Virginia
Co-authored papers 4
Viraj Kulkarni
Texas Biomedical Research Institute
Co-authored papers 4
Rama Rao Amara
Co-authored papers 4
Dinesh Hariraju
Texas Biomedical Research Institute
Co-authored papers 4
Celia C LaBranche
Co-authored papers 3
Kenneth A Rogers
Co-authored papers 3
Dimiter S Dimitrov
Co-authored papers 3
Galit Alter
Co-authored papers 3
Judy Lieberman
Boston Children's Hospital
Co-authored papers 3
Amanda L Strickland
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Byung Park
Oregon Health & Science University
Co-authored papers 2
Barton F Haynes
Co-authored papers 2
Elizabeth Plake
Texas Biomedical Research Institute
Co-authored papers 2
John R Mascola
Co-authored papers 2
Khamis Tomusange
Texas Biomedical Research Institute
Co-authored papers 2
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 2
Kenneth H Mayer
Co-authored papers 2
Jane Fontenot
Co-authored papers 2
Jack T Stapleton
Co-authored papers 1
Temple F Smith
Co-authored papers 1
David H O'Connor
Co-authored papers 1
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Opeyemi S Adeniji
The Wistar Institute
Co-authored papers 1
Ann Marshak-Rothstein
University of Massachusetts School of Medicine
Co-authored papers 1
Release 1.2